Fifth Third Wealth Advisors LLC Invests $507,000 in Avantor, Inc. (NYSE:AVTR)

Fifth Third Wealth Advisors LLC acquired a new position in shares of Avantor, Inc. (NYSE:AVTR) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 19,603 shares of the company’s stock, valued at approximately $507,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Intech Investment Management LLC increased its position in shares of Avantor by 1.8% in the 2nd quarter. Intech Investment Management LLC now owns 29,068 shares of the company’s stock valued at $616,000 after buying an additional 514 shares in the last quarter. Arizona State Retirement System increased its position in shares of Avantor by 0.3% in the 2nd quarter. Arizona State Retirement System now owns 186,567 shares of the company’s stock valued at $3,955,000 after buying an additional 528 shares in the last quarter. Veracity Capital LLC increased its position in shares of Avantor by 1.0% in the 3rd quarter. Veracity Capital LLC now owns 52,359 shares of the company’s stock valued at $1,355,000 after buying an additional 543 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of Avantor by 2.8% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company’s stock valued at $571,000 after buying an additional 733 shares in the last quarter. Finally, US Bancorp DE boosted its stake in Avantor by 6.2% in the 3rd quarter. US Bancorp DE now owns 12,615 shares of the company’s stock worth $326,000 after purchasing an additional 734 shares during the period. Institutional investors own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on AVTR shares. Robert W. Baird reduced their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Wells Fargo & Company reduced their target price on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. TD Cowen upped their target price on shares of Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. UBS Group reduced their price objective on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research note on Tuesday, October 8th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $34.00 target price on shares of Avantor in a research note on Thursday, September 26th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, Avantor currently has an average rating of “Moderate Buy” and an average price target of $27.57.

Avantor Price Performance

AVTR stock opened at $20.14 on Thursday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. Avantor, Inc. has a 52 week low of $19.49 and a 52 week high of $28.00. The firm’s fifty day moving average is $24.14 and its 200 day moving average is $23.91. The firm has a market cap of $13.71 billion, a P/E ratio of 43.78, a P/E/G ratio of 2.52 and a beta of 1.35.

Insider Transactions at Avantor

In related news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the transaction, the chief accounting officer now directly owns 29,544 shares in the company, valued at $740,372.64. This trade represents a 10.66 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.